Navigation Links
Columbia research lifts major hurdle to gene therapy for cancer

Researchers at Columbia University Medical Center have discovered a way to overcome one of the major hurdles in gene therapy for cancer: its tendency to kill normal cells in the process of eradicating cancer cells. In a new study published in the Jan. 25 issue of the Proceedings of the National Academy of Sciences (PNAS), the researchers demonstrated that the technique works by incorporating it into a specially designed virus. The virus eradicated prostate cancer cells in the lab and in animals while leaving normal cells unscathed.

Gene therapy based on the new technique should also be effective for a wide range of tumors - such as ovarian, breast, brain (glioma), skin (melanoma) and colon cancer - because the virus is constructed to exploit a characteristic of all solid cancers. "What's exciting is we may now be able to design a therapy that will seek out and destroy only cancer cells," said the study's senior author, Paul B. Fisher, Ph.D., professor of clinical pathology and Michael and Stella Chernow Urological Cancer Research Scientist at Columbia University Medical Center. "We hope it will be particularly powerful in eradicating metastases that we can't see and that can't be eliminated by surgery or radiation. Gene therapy, especially for cancer, is really starting to make a comeback." The virus's selectivity for cancer cells is based on two molecules called PEA-3 and AP-1 that, the researchers found, are usually abundant inside cancer cells. Both of the molecules flip a switch (called PEG) that turns on the production of a cancer-inhibiting protein uniquely in tumor cells. The researchers say the PEG switch can be exploited to produce gene therapies that will only kill cancer cells even if the therapy enters normal cells. As an example, the researchers constructed an adenovirus that carries the PEG switch and a toxic protein. The switch and the protein were connected to each other so that the deadly protein is only unleashed inside cancer cells when the
'"/>

Source:Eurekalert


Page: 1 2

Related biology news :

1. Columbia study shows widely used artery clearing device does not help patients during heart attack
2. Columbia scientists develop cancer terminator viruses
3. Contaminants linked to sturgeon decline in Columbia river
4. Columbia University licenses next-generation DNA sequencing technology
5. New bird discovered on unexplored Columbian mountain
6. Columbia scientists determine 3-dimensional structure of cells fuel gauge
7. U of M researcher examines newly emerging deadly disease
8. NYU researchers simulate molecular biological clock
9. First atlas of key brain genes could speed research on cancer, neurological diseases
10. New research questions basic tenet of neuron function
11. Vital step in cellular migration described by UCSD medical researchers

Post Your Comments:
(Date:11/19/2009)...rtant crop in many countries of the world. It is w... industrial materials. It also is considered an ex...olecular evolution, and genome architecture. The a...ollection used the first description of the B73 ma...estions in genetics and plant biology. The ten pap...
(Date:11/19/2009)...L, N.J., Nov. 19 BIO-key... leader in wireless public safety and finger-based...t the Special Shareholder Meeting held today was a...quorum was not present. ,, (Logo: http://www.n... While an impressive 99.3% of the 35 million votes...
(Date:11/19/2009)...Ind. - Purdue University scientists have helped id...le for cell wall development in maize, an effort t...uce the biomass best suited for biofuels productio...ita, a professor of plant cell biology, published ...ournal Plant Physiology on Thursday (Nov. 19). T...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Maize cell wall genes identified, giving boost to biofuel research 2Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 1Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 2Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 3Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 4Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 5Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 6Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 7Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 8Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 9Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 10Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 11Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 12Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 13Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 14Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 15Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 16Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 17Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 18Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 19Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 20CSC Announces Agreement to Provide Billing Service to Littleton Internal Medicine Associates 51724 1Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 1Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 2
...ess endothelin-1,s power to constrict blood vessel...heart failure, scientists must learn more about ho...ates, says a Medical College of Georgia researcher...ing endothelin-1 receptors would be an effective, ...ms, the drugs failed patients, says Dr. Adviye Erg...
...press release is available in French and Spanis...(Spain) and the San Cecilio Teaching Hospital (Gra...s for the blindness produced by corneal oedema and...earch group of Tissue Engineering of the UGR and...ntly constructed the first complete artificial cor...
... from the worlds of law, geography, economics, pub...versity College London) on Friday September 19th t...an become locally-rooted champions for global sust... help bring about lasting change. The symposium, w...ing Ecological Thinking, Learning and Research", w...
Other Biology News:Better understanding of blood vessel constrictor needed to harness its power for patients 2Scientists identify the genes that cause blindness produced by corneal edema 2Universities develop a more sustainable future 2
(Date:11/20/2009)...rstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq ...uit Court of Appeals reversed a U.S. District Cour...rsue all of its claims against The Lash Group, sen.... CTI filed a complaint against The Lash Group, C...or CTI,s product TRISENOX, in 2007 seeking $22.8 m...
(Date:11/19/2009)...Danish Prince Joachim inaugurated the DONG Energy ..., Denmark, on Wednesday, November 18. The facility...ation ethanol demonstration biorefineries. Genenco...novative process for converting straw to fuel. Gen...ket with commercial enzymes for converting cellulo...
(Date:11/19/2009)...Call/ -- NeoStem, Inc. (NYSE Amex: NBS ), announc...its shareholders, discussing the Company,s acquisi...cals Holdings, Inc. (CHBP), an integrated bio-phar...of China. The merger gives NeoStem a controlling 5..., CHBP,s primary operating subsidiary and a promin...
(Date:11/19/2009)...gera Therapeutics Inc. announced today the dosing ...y of AEG35156, a targeted antisense therapeutic in...ations. ,, The study, entitled "An Open-Label R...of Apoptosis (XIAP) Antisense AEG35156 Given in Co... in AML Following Failure of a Single Standard Dos...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...d., June 11 Zimmer Holdings, Inc.,(NYSE: ZMH ; S...in the,William Blair & Company 28th Annual Growth ...2008, at 8:30 a.m. Eastern Time., A live webcast ...nvestor Relations website at http://investor.zimm...following the conference., About the Company, Fo...
...nomics has Signed a Binding Term Sheet to Acquire ...ning a Clinical Laboratory Improv...Intended to Significantly Streamline the Developme...croRNA-based Diagnostics, Owning a CLIA-certified ...,it Needs to Market and Sell its microRNA-based Te...
...onn., June 11 Biodel Inc. (Nasdaq:,BIOD) today an... elected as,a new member of its Board of Directors...ly Chief Executive Officer of Diabetes Technology,... in the field of,diabetes., "We are pleased to we...mportant time for Biodel," stated Dr. Solomon Stei...
Other Biology Technology:Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 2Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 3Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 4Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 5Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests 6Barry Ginsberg, M.D., Ph.D. Elected to Biodel's Board of Directors 2
Feline IFN Alpha from PBL InterferonSource
RapidStak 2 (requires 4 staks, not included) from Thermo Scientific
Wellwash 4 Mk 2 from Thermo Scientific
Multi-Chamber Dispenser from Terra Universal, Inc.
Biology Products: